Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2007
09/12/2007CN101032545A Novel purpose of Chinese traditional medicine homonoia riparia
09/12/2007CN101032540A Medicine composition for curing arthritis and the preparing method and purpose thereof
09/12/2007CN101032523A Royal jelly acid calcium and preparation process thereof
09/12/2007CN101032483A Composing of hydantoin ramification for adjusting estrogen receptor activity and application thereof
09/12/2007CN101032476A Medical combination including rhein or diacetylrhein and the preparing method thereof
09/12/2007CN101032433A Traditional Chinese medicine magnetic therapeutic pillow
09/12/2007CN101032336A Pearl flavone nutrient health care food and preparation process thereof
09/12/2007CN101032303A Compound food gum producing process
09/12/2007CN100336825C Renaturation of reconstituted human bone protein-1 and making method of its preparation
09/12/2007CN100336554C Chinese herbal plant medicinal oil
09/12/2007CN100336545C Medicinal wine with aizoon stonecrop for treating blood vessel disease and its preparation method
09/12/2007CN100336542C Glabrous greenbrier total saponin extract and its prepn and use
09/12/2007CN100336541C Chinesle herbal medicine liquor
09/12/2007CN100336527C Medicine for treating celevical vertebra disease
09/12/2007CN100336521C Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
09/12/2007CN100336501C Cuyantong slow-releasing round-particle composition and preparation method
09/11/2007US7268213 Glucagon-like peptide-1 (glp-1) receptor agonist
09/11/2007US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents
09/11/2007US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression
09/11/2007US7268138 Compounds, methods and pharmaceutical compositions for inhibiting PARP
09/11/2007US7268128 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases
09/11/2007US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal
09/11/2007US7268112 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form
09/11/2007US7268111 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound
09/11/2007US7267963 Modified plant viruses and methods of use thereof
09/11/2007CA2372720C Androgen glycosides and androgenic activity thereof
09/11/2007CA2187210C Method for purifying diacetylrhein
09/09/2007CA2638622A1 Peripheral and neural inflammatory crosstalk
09/07/2007WO2007100643A2 Methods of using antibodies against human il-22
09/07/2007WO2007100282A1 New salts of an indole derivative and their use in medicine
09/07/2007WO2007100058A1 Rheumatoid arthritis test method and treating method
09/07/2007WO2007099432A2 Pharmaceutical composition containing butea isoflavones for the prevention /treatment of bone disorders and a process for the preparation thereof
09/07/2007WO2007081879A3 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
09/07/2007WO2007064304A8 Biocompatible composition and uses thereof
09/07/2007CA2643973A1 Pharmaceutical composition containing butea isoflavones for the prevention /treatment of bone disorders and a process for the preparation thereof
09/07/2007CA2642570A1 Methods of using antibodies against human il-22
09/06/2007US20070208066 ER-beta-selective ligands
09/06/2007US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators
09/06/2007US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
09/06/2007US20070208033 Amine compound and use thereof
09/06/2007US20070208025 Novel pyridazine derivatives and medicines containing the same as effective ingredients
09/06/2007US20070208016 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions
09/06/2007US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity
09/06/2007US20070207957 Composition For Accelerating Alcohol Metabolism Or Relieving Fatigue By Gluconeogenesis
09/06/2007US20070207163 Recombinant soluble Fc receptors
09/06/2007US20070207153 Therapeutic Agents For Inner Ear Disorders Containing An Il-6 Antagonist As An Active Ingredient
09/06/2007DE102006009799A1 Vorwiegend plättchenförmige schwer wasserlösliche Calciumsalze und/oder deren Kompositmaterialien, umfassend diese Mostly flaky poorly water-soluble calcium salts and / or composite materials comprising them
09/05/2007EP1829888A1 Anti-inflammatory compounds and uses thereof
09/05/2007EP1829881A1 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same
09/05/2007EP1829536A1 Ameliorant for renal insufficiency
09/05/2007EP1828193A1 Pyridil-substituted spiro-hydantoin compounds and use thereof
09/05/2007EP1828169A2 Urea inhibitors of map kinases
09/05/2007EP1828166A1 Hydantoin derivatives useful as metalloproteinase inhibitors
09/05/2007EP1828109A2 Guanidine derivatives as inhibitors of ddah
09/05/2007EP1827476A2 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
09/05/2007EP1827430A1 Nanoparticulate benzothiophene formulations
09/05/2007EP1827413A1 Use of cyclodextrin complexes containing lipoic acid
09/05/2007EP1545564B1 Combination preparation of hyaluronic acid and lidocaine and the use thereof
09/05/2007EP1474419B1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
09/05/2007EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
09/05/2007EP1345598B1 The use of rosiglitazone for treating psychiatric disorders.
09/05/2007EP1100829B1 Use of basiliximab in the treatment of rheumatoid arthritis or skin diseases
09/05/2007CN101029080A Methods and compositions for derepression of IAP-inhibited caspase
09/05/2007CN101028552A Bee-glue medicinal cervical vertebrae pillow
09/05/2007CN101028519A Pharmaceutical composition for treating immune diseases
09/05/2007CN101028504A Gubiping instant granules and production thereof
09/05/2007CN101028481A Medicinal liquor for treating hyperosteogency and koilorrhachic
09/05/2007CN101028472A Oral Chinese medicinal composition for treating lumbocostal overstrain
09/05/2007CN101028454A Externally-applied bone-set plaster and its production
09/05/2007CN101028403A Oral Chinese-medicinal composition for treating omitis
09/05/2007CN101028400A Xue Shang Hua embrocation and its production
09/05/2007CN101028366A Externally-applied Chinese medicinal composition for treating psoatic strain
09/05/2007CN101028354A Quality controlling method of siegesbeckia orientalis tablets
09/05/2007CN101028353A Keeled cervical vertebrae medicine and its production
09/05/2007CN101028325A Medicinal composition containing sailonggu, and its preparation and quality control
09/05/2007CN101028304A Chinese medicine for treating rheumatic arthritis
09/05/2007CN101028300A Chinese medicine for treating rheumatic arthralgia
09/05/2007CN101028283A Use of fucans in the treatment of adhesions, arthritis and psoriasis
09/05/2007CN101028268A Pharmaceutical compositions
09/05/2007CN101028258A Medicinal composition containing ibuprofen
09/05/2007CN101028058A Bone gourmet powder and its production
09/05/2007CN101028053A Preparing and preserving method for Wubao liquid
09/05/2007CN100335478C Chemokine receptor binding heterocyclic compounds
09/05/2007CN100335464C Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
09/05/2007CN100335111C Medicine for rheumatism and its preparation
09/05/2007CN100335082C Medicine for treating rheumarthritis
09/05/2007CN100335079C Oral Chinese medicine preparation of caput femoris ischemic necrosis and production thereof
09/05/2007CN100335059C Medicine composition and its use
09/05/2007CN100335051C Novel use of medicinal formulation capable of improving cerebral metabolism for preventing and treating osteoporosis
09/04/2007US7265227 Piperidine derivatives useful as modulators of chemokine receptor activity
09/04/2007US7265221 Pyrrolo[2,3-d]pyrimidine compounds
09/04/2007US7265208 Autoimmune disease; allergies vaccine
09/04/2007US7265203 Human cytokine receptor
09/04/2007US7265146 Administering small molecule compounds, especially acids or esters, that inhibit the interaction between alpha 4 integrins and ligands MAdCAM and/or VCAM for treatment of chronic inflammatory diseases such as arthritis, asthma, multiple sclerosis, Chrohn's disease, ulcerative colitis, and hepatitis C
09/04/2007US7265139 RXR activating molecules
09/04/2007US7265137 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders
09/04/2007US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases
09/04/2007US7265125 4-Heteroaminoquinazoline derivatives,.e.g., 2-methyl-4-piperidin-1-yl-7-pyridin-3-yl-quinazoline; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity.
09/04/2007US7265123 Heterocyclic compounds
09/04/2007US7265113 Anticancer agents; antiinflammatory agents, for therapy of rheumatoid arthritis